Ring finger protein 213 c.14576G>A mutation is not involved in internal carotid artery and middle cerebral artery dysplasia.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
12 11 2021
Historique:
received: 06 07 2021
accepted: 01 11 2021
entrez: 13 11 2021
pubmed: 14 11 2021
medline: 27 1 2022
Statut: epublish

Résumé

The ring finger protein 213 (RNF213) susceptibility gene has been detected in more than 80% of Japanese and Korean patients with moyamoya disease (MMD), a bilateral internal carotid artery (ICA) occlusion. Furthermore, RNF213 has been detected in more than 20% of East Asians with atherosclerotic ICA stenosis. In this study, we evaluated the frequency of RNF213 mutations in congenital occlusive lesions of the ICA system. This case series was conducted jointly at four university hospitals. Patients with a family history of MMD, quasi-MMD, or related diseases were excluded. Ten patients were diagnosed with abnormal ICA or middle cerebral artery (MCA) angiogenesis. Patients with neurofibromatosis were excluded. Finally, nine patients with congenital vascular abnormalities were selected; of these, five had ICA deficiency and four had twig-like MCA. The RNF213 c.14576G > A mutation was absent in all patients. Therefore, the RNF213 c.14576G > A mutation may not be associated with ICA and MCA congenital dysplasia-rare vascular anomalies making it difficult to study a large number of cases. However, an accumulation of cases is required for accurate determination. The results of this study may help differentiate congenital vascular diseases from MMD.

Identifiants

pubmed: 34773068
doi: 10.1038/s41598-021-01623-6
pii: 10.1038/s41598-021-01623-6
pmc: PMC8589854
doi:

Substances chimiques

RNF213 protein, human EC 2.3.2.27
Ubiquitin-Protein Ligases EC 2.3.2.27
Adenosine Triphosphatases EC 3.6.1.-

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

22163

Informations de copyright

© 2021. The Author(s).

Références

J Stroke Cerebrovasc Dis. 2018 Aug;27(8):2259-2270
pubmed: 29752070
Int J Mol Sci. 2017 Nov 21;18(11):
pubmed: 29160859
Front Neurol. 2021 Mar 02;12:637310
pubmed: 33737903
PLoS One. 2017 Apr 17;12(4):e0175649
pubmed: 28414759
Respir Med Case Rep. 2019 Dec 14;29:100977
pubmed: 31908915
Neurology. 1968 Dec;18(12):1149-56
pubmed: 5750702
J Hum Genet. 2011 Jan;56(1):34-40
pubmed: 21048783
Am J Med Genet A. 2016 Sep;170(9):2453-6
pubmed: 27375007
Neurosurgery. 2012 Jun;70(6):1472-80; discussion 1480
pubmed: 22186843
Neurol India. 2013 Jan-Feb;61(1):35-9
pubmed: 23466837
Surg Neurol Int. 2015 Mar 20;6:41
pubmed: 25883833
Neurosurg Focus. 2021 Sep;51(3):E2
pubmed: 34469872
Ann Transl Med. 2020 Jul;8(14):851
pubmed: 32793695
Environ Health Prev Med. 2017 Nov 02;22(1):75
pubmed: 29165161
Stroke. 2012 Dec;43(12):3371-4
pubmed: 23010677
Neurol Med Chir (Tokyo). 2012;52(5):245-66
pubmed: 22870528
Transl Stroke Res. 2020 Aug;11(4):580-589
pubmed: 31650369
No Shinkei Geka. 2020 Jun;48(6):533-540
pubmed: 32572006
World Neurosurg. 2017 Mar;99:701-708.e1
pubmed: 28063898
J Hum Genet. 2011 Feb;56(2):166-8
pubmed: 21179104
PLoS One. 2012;7(10):e48179
pubmed: 23110205
J Stroke Cerebrovasc Dis. 2017 Nov;26(11):2638-2644
pubmed: 28797616
Stroke. 2013 Oct;44(10):2894-7
pubmed: 23970789
World Neurosurg. 2020 Sep;141:192-195
pubmed: 32438004
J Neurosurg. 2016 May;124(5):1221-7
pubmed: 26430847
Stroke. 2020 Jun;51(6):1647-1655
pubmed: 32390555
J Stroke Cerebrovasc Dis. 2018 Oct;27(10):2892-2893
pubmed: 30093206
Neurology. 2020 Feb 18;94(7):e678-e686
pubmed: 31949090
PLoS One. 2011;6(7):e22542
pubmed: 21799892
J Neurosurg. 1975 Apr;42(4):478-82
pubmed: 1123670
Environ Health Prev Med. 2017 Apr 24;22(1):41
pubmed: 29165136
J Hum Genet. 2018 May;63(5):687-690
pubmed: 29500468
J Stroke Cerebrovasc Dis. 2020 Feb;29(2):104549
pubmed: 31818681

Auteurs

Yasuo Murai (Y)

Department of Neurological Surgery, Nippon Medical School, Bunkyo-ku, Tokyo, 113-8603, Japan. ymurai@nms.ac.jp.

Eitaro Ishisaka (E)

Department of Neurological Surgery, Nippon Medical School, Bunkyo-ku, Tokyo, 113-8603, Japan.

Atsushi Watanabe (A)

Division of Clinical Genetics, Kanazawa University Hospital, Kanazawa, Ishikawa, 920-8604, Japan.
Support Center for Genetic Medicine, Kanazawa University Hospital, Kanazawa, Ishikawa, 920-8604, Japan.

Tetsuro Sekine (T)

Department of Radiology, Nippon Medical School Musashi-Kosugi Hospital, Kanagawa, 211-8533, Japan.

Kazutaka Shirokane (K)

Department of Neurological Surgery, Nippon Medical School, Bunkyo-ku, Tokyo, 113-8603, Japan.

Fumihiro Matano (F)

Department of Neurological Surgery, Nippon Medical School, Bunkyo-ku, Tokyo, 113-8603, Japan.

Ryuta Nakae (R)

Department of Emergency and Critical Care Medicine, Nippon Medical School Hospital, Tokyo, 113-8602, Japan.

Tomonori Tamaki (T)

Department of Neurosurgery, Nippon Medical School Tama Nagayama Hospital, Tokyo, 206-8152, Japan.

Kenta Koketsu (K)

Department of Neurological Surgery, Nippon Medical School, Bunkyo-ku, Tokyo, 113-8603, Japan.

Akio Morita (A)

Department of Neurological Surgery, Nippon Medical School, Bunkyo-ku, Tokyo, 113-8603, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH